Kiora Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-15,951 | $0 |
Gross Profit | -31 | -19 | -15,985 | -14 |
EBITDA | -2,233 | -2,054 | -2,500 | -2,696 |
EBIT | -2,264 | -2,055 | -2,506 | -2,698 |
Net Income | -2,152 | -2,192 | -4,223 | -3,413 |
Net Change In Cash | 0 | 0 | -15,951 | 0 |
Free Cash Flow | -3,835 | -2,704 | -2,207 | 920 |
Cash | 1,028 | 3,771 | 3,792 | 5,637 |
Basic Shares | 3,989 | 4,217 | 3,000 | 4,214 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $16,020 | $0 | $0 | $12 |
Gross Profit | 16,000 | -4,027 | -134 | -227 |
EBITDA | 5,746 | -12,350 | -10,685 | -13,729 |
EBIT | 5,681 | -12,412 | -10,726 | -13,956 |
Net Income | 3,594 | -12,513 | -13,583 | -16,394 |
Net Change In Cash | 16,020 | 0 | 0 | 12 |
Free Cash Flow | 8,552 | -9,556 | -10,428 | -10,951 |
Cash | 3,792 | 2,454 | 5,964 | 7,854 |
Basic Shares | 4,125 | 538 | 732 | 241 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.54 |
2025-03-31 | -$0.52 |
2024-12-31 | -$1.20 |
2024-09-30 | -$0.81 |
